The S&P/ASX 300 Index (ASX: XKO) finished just inside the green on Thursday, up 0.07% to 8,146 points.
In a lacklustre day of trading, these six companies stood out by hitting new price benchmarks today.
Image source: Getty Images
6 ASX 300 shares that powered to new peaks on Thursday
Goodman Group (ASX: GMG)
Australia's largest real estate investment trust (REIT) hit an all-time record high of $37.80.
There was no price-sensitive news from the real estate giant today.
Goodman Group is leveraging the tailwind of artificial intelligence (AI) by developing and acquiring data centres in key locations worldwide.
The company will hold its annual general meeting in Sydney on 14 November.
The ASX 300 property share has risen 78% over the past 12 months.
Sigma Healthcare Ltd (ASX: SIG)
This pharmacy chain operator and wholesaler enjoyed a third consecutive day of gains on Thursday.
The Sigma share price closed at a new 52-week milestone of $2.06 today.
There was no news from the company on Thursday. However, the ASX 300 health care share has been rising following an update on its proposed acquisition of Chemist Warehouse.
Sigma has offered to make court-enforceable undertakings in response to a list of concerns put forward by the Australian Competition and Consumer Commission (ACCC).
These include potential harm to pharmacies that Sigma currently supplies and the potential for Chemist Warehouse to access the data of those businesses in a way that would damage competition.
In response to the news, ACCC chair Gina Cass-Gottlieb said: "We are now seeking feedback from stakeholders on whether the draft undertaking offered by Sigma may be capable of addressing the competition concerns arising from its proposed acquisition of Chemist Warehouse."
The ASX 300 healthcare share is up 217% over the past 12 months.
Brambles Ltd (ASX: BXB)
The Brambles share price hit a new all-time record high of $19.09 today.
There was no price-sensitive news from the Chep wooden pallet manufacturer and distributor today.
The ASX 300 industrial share has risen 32% over the past 12 months.
Mesoblast Ltd (ASX: MSB)
The Mesoblast share price shot to a new 52-week high of $1.40 on Thursday.
Mesoblast shares have shot the lights over the past five days of trading, up 23%.
Last Friday, the company announced it had entered into a convertible note subscription agreement with its largest shareholder.
Under the deal, Mesoblast will have the option to issue up to US$50 million in convertible notes if the United States Food and Drug Administration (FDA) approves its lead product candidate, remestemcel-L.
The drug treats steroid-refractory acute graft versus host disease (SR-aGvHD) in children. Mesoblast resubmitted the drug for consideration in July after conducting more trials at the FDA's request.
The funding would enable Mesoblast to immediately get cracking on its go-to-market commercial strategy. Mesoblast anticipates a decision prior to or on the FDA's goal date of 7 January 2025.
The ASX 300 biotech share is up 255% over the past 12 months.
TechnologyOne Ltd (ASX: TNE)
TechnologyOne hit a new all-time record high of $24.41 despite no price-sensitive news today.
The ASX 300 tech share has lifted 60% over the past 12 months.
Regis Healthcare Ltd (ASX: REG)
Stock in this residential aged care services provider hit a 52-week high of $6.46 on Thursday.
Regis did not release any news today. However, the company may be benefitting from proposed reforms that would see new care residents having to make larger means-tested contributions.
The ASX 300 healthcare share is up 140% over the past 12 months.
